RxDoctor Payments DataLook up a doctor →

Michael Zimmerman, MD

Emergency Medicine · Austin, TXNPI 1518909647

Payments from drug & device makers

$4,701,017in general payments, 2019–2025

Across 517 payments — averaging $9092.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$1.6M
  • Modernatx, Inc.$1.3M
  • Eli Lilly$400K
  • Boehringer Ingelheim International GmbH$326K
  • Bavarian Nordic A/s$275K
  • Currax Pharmaceuticals LLC$236K
  • plus $623K from 13 others
$10,410in research payments, 2019–2025

Across 3 payments — averaging $3470.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$10K

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,701,017 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.

See all emergency medicine providers in Texas

Medicare billing

Part B allowed, 2024
$7,283
Medicare patients
50
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other emergency medicine in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →